NeuroMetrix, Inc. (NASDAQ:NURO)
CAPS Rating:
The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.
Growing the love for investing
The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Over reaction to potentially bad news drove this stock lower than warranted. Should rebound to the 30's by early 2007.